If you notice any issues or missing content, please let us know. Your feedback helps us improve. Thank you.
Principal Investigator
Dr. Akash Chaurasiya
Funding Agency
Slayback Pharma
Type of Project
Industry
Sanction Amount (INR)
7.02
Status
Completed
Literature Search of LAI Development and Adverse Event Level
Topical nanomicelles eyedrop for delivering antifungal drug to treat corneal infection
This website uses cookies or similar technologies, to enhance your browsing experience.